Stromal Prognostic Markers for Oral Cancer: An Update
Oral Diseases · 2025-07 · 31 (7) · 2019-2025
DOI: 10.1111/odi.15278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oral Diseases, online erschienen am 03.03.2025. Verfasst von Everton Freitas de Morais und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Diagnosis, and Graduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mouth Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell, Stromal Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
This article aims to provide a broad overview of the oral squamous cell carcinoma (OSCC) tumor stroma, describing and discussing recent advances in the understanding of different stromal elements and their roles in tumor progression. We also describe potential new therapeutic approaches targeting the stroma.
Methods
A literature review on the role of stromal biomarkers in OSCC was conducted. A narrative overview of current literature was undertaken to synthesize the contexts with elaboration and summary.
Results
The crosstalk between cancer cells and the tumor stroma, a major driver of tumor progression and metastasis, has increasingly been unveiled. This review highlights the tumor‐to‐stroma ratio (TSR) as a valuable prognostic marker in OSCC, with high stromal content (TSR > 50%) linked to poorer survival. On the other hand, tumor‐infiltrating lymphocytes are associated with improved prognosis and longer survival. Furthermore, emerging markers, such as cancer‐associated fibroblasts and desmoplastic reactions, play significant roles in promoting tumor invasiveness and resistance to therapy. The review identifies gaps in current evidence and proposes directions for future research to further clarify the prognostic utility of stromal components.
Conclusions
Stromal markers provide valuable prognostic insights into OSCC and could enhance clinical decision‐making, emphasizing the complexity of OSCC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Diagnosis, and Graduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, São Paulo, Brazil.
- Department of Otorhinolaryngology, Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Institute of Biomedicine, Pathology, University of Turku, Turku, Finland.
- Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
- Faculty of Dentistry, Misurata University, Misurata, Libya.
ORCID-Profile: Everton Freitas de Morais, Ricardo D Coletta, Alhadi Almangush
Zitieren
APA
de Morais, E. F., Mäkitie, A., Coletta, R. D., & Almangush, A. (2025). Stromal Prognostic Markers for Oral Cancer: An Update. Oral Diseases, 31(7), 2019-2025. https://doi.org/10.1111/odi.15278
Vancouver
de Morais EF, Mäkitie A, Coletta RD, Almangush A. Stromal Prognostic Markers for Oral Cancer: An Update. Oral Diseases. 2025;31(7):2019-2025. doi:10.1111/odi.15278
BibTeX
@article{deMorais2025,
author = {de Morais, Everton Freitas and Mäkitie, Antti and Coletta, Ricardo D and Almangush, Alhadi},
title = {Stromal Prognostic Markers for Oral Cancer: An Update},
journal = {Oral Diseases},
year = {2025},
volume = {31},
number = {7},
pages = {2019--2025},
doi = {10.1111/odi.15278}
}
EUVIMED